Crescent Grove Advisors, LLC Xtant Medical Holdings, Inc. Transaction History
Crescent Grove Advisors, LLC
- $980 Million
- Q2 2025
A detailed history of Crescent Grove Advisors, LLC transactions in Xtant Medical Holdings, Inc. stock. As of the latest transaction made, Crescent Grove Advisors, LLC holds 412,024 shares of XTNT stock, worth $276,056. This represents 0.03% of its overall portfolio holdings.
Number of Shares
412,024
Previous 212,024
94.33%
Holding current value
$276,056
Previous $99,000
207.07%
% of portfolio
0.03%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding XTNT
# of Institutions
32Shares Held
80MCall Options Held
0Put Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT68.4MShares$45.8 Million2.21% of portfolio
-
Awm Investment Company, Inc. New York, NY6.6MShares$4.42 Million0.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$1.51 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny651KShares$435,9750.0% of portfolio
-
Geode Capital Management, LLC Boston, MA554KShares$370,9280.0% of portfolio
About Xtant Medical Holdings, Inc.
- Ticker XTNT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 108,226,000
- Market Cap $72.5M
- Description
- Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...